36th Annual Pittsburgh Schizophrenia Conference

Pittsburgh, PA US
November 15, 2019

The Pittsburgh Schizophrenia Conference is an annual meeting at which the advances in schizophrenia research are reviewed by experts in the field. This year’s meeting will cover early identification and management of first episode psychoses based on knowledge obtained and disseminated from a NIMH funded trial. Attendees will learn and review immune-inflammatory mechanisms that play a role in subgroups of persons with schizophrenia, especially gluten sensitivity and ongoing work to remediate this sensitivity. Participants will hear about transcranial magnetic stimulation (TMS) and its potential use in schizophrenia. From a case example, attendees will learn about clarifying diagnosis and optimizing medications in persons with mental illness in a residential facility. Finally, attendees will hear from people with serious mental illness who will share their stories of working as Peer Specialists and of using music to help support their recovery.

Target Audience

The conference is designed to disseminate the latest clinical and research findings to a wide audience: psychiatrists and other mental health clinicians, including nurses, social workers, psychologists, service coordinators, researchers, patients and their relatives, mental health policy administrators and others who intend to keep current regarding treatment research in schizophrenia.

Learning Objectives

At the completion of the program, participants should be able to:

1. Recognize the essential elements of coordinated specialty care early in the course of schizophrenia.

2. Recognize the concept of the duration of untreated psychoses and steps taken to reduce the duration.

3. Discuss ongoing research to characterize a subgroup of schizophrenia patients with immune response and inflammation to gluten.

4. Identify potential pathophysiologic mechanisms related to an immune response to gluten.

5. Explain ongoing work for personalizing treatment in this subgroup of schizophrenia with potential gluten sensitivity.

6. Recognize the basic mechanisms of non-invasive brain activity modulation with TMS.

7. Review the safety profile of TMS treatments.

8. Review studies investigating the use of TMS in patients with schizophrenia and psychotic disorders.

9. Discuss if a step down longer stay residential placement provides value for clarifying the diagnosis and revisit the treatment approach to persons with serious mental illness.

Additional Information

AttachmentSize
CME Handout (002) APPROVED.pdf247.17 KB
Course summary
Available credit: 
  • 6.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.50 Attendance
Course opens: 
11/15/2019
Course expires: 
12/31/2020
Event starts: 
11/15/2019 - 7:00am
Event ends: 
11/15/2019 - 6:00pm

7:30 am Registration and Continental Breakfast

8:30 am Introduction and Background K.N. Roy Chengappa, MD

8:45-10:15 am The Gerard E. Hogarty Excellence in Schizophrenia Research Memorial Award

8:45 to 9:00 am Review of Dr. Kane’s work

Shaun M. Eack, PhD

Presentation of plaque to John M. Kane, MD

Susan Hogarty, RN, MSN

9:00-10:15 am Gerard E. Hogarty Excellence in Schizophrenia Research

Memorial Lecture

Lessons Learned from RAISE-ETP: Where Do We Go from Here?

John M. Kane, MD

9:00 to 10:00 Presentation

10:00 to 10:15 Q&A session

10:15-10:30 am Break

10:30-11:45 am Gluten and Schizophrenia: New Target and Precision Medicine?

Deanna L. Kelly, Pharm.D., BCPP

10:30-11:30 Presentation

11:30-11:45 Q&A session

11:45-1:00 pm Lunch (on own)

1:00-2:15 pm Transcranial Magnetic Stimulation (TMS) in Schizophrenia and Psychosis – 2019 Update

Steven D. Forman MD, PhD

1:00-2:00 Presentation

2:00-2:15 Q&A session

2:15 – 3:30 pm Deprescription and Optimization of Medications

Vernon Nathaniel, MD

Susan Wolfe, MA LPC, Program Director CTT

Stacy Martin, LSW, Behavioral Health Counselor

2:15-3:15 Presentation

3:15-3:30 Q&A session

3:30 - 3:40 pm Break

3:40 – 4:40 pm Peer Specialists: Sharing and Working

Susan Brown Padilla, CPS, Senior Peer Specialist

Bernice Hayes, CPS, Senior Peer Specialist

Flavio Chamis, Music Director and peer musicians

4:40-4:50 Closing Remarks and Adjournment K.N. Roy Chengappa, MD

Sheraton Pittsburgh Hotel at Station Square
300 W Station Square Dr.
Pittsburgh, PA 15219
United States

Course Director

K.N. Roy Chengappa, MD

Professor of Psychiatry

University of Pittsburgh School of Medicine

Chief, Comprehensive Recovery Services

UPMC Western Psychiatric Hospital

Pittsburgh, PA

 

Gerard E. Hogarty Excellence in Schizophrenia Research Memorial Award Winner

John M. Kane, MD

Senior Vice President for Behavioral Health Services

Northwell Health

New Hyde Park, NY

Professor and Chairman

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

The Zucker Hillside Hospital

Glen Oaks, NY

 

Faculty

Steven D. Forman MD, PhD

Staff Physician & Research Investigator

Program Chief, Transcranial Magnetic Stimulation Clinic

VA Pittsburgh Healthcare System

Assistant Professor of Psychiatry

University of Pittsburgh School of Medicine

Pittsburgh, PA

 

Bernice Hayes, CPS Senior Peer Specialist UPMC Western Psychiatric Hospital Pittsburgh, PA

Deanna L. Kelly, PharmD., BCPP Professor of Psychiatry Director, Treatment Research Program (TRP) Maryland Psychiatric Research Center (MPRC) University of Maryland School of Medicine

Shaun M. Eack, PhD David E. Epperson Professor of Social Work Professor of Psychiatry School of Social Work and Department of Psychiatry University of Pittsburgh UPMC Western Psychiatric Hospital Pittsburgh, PA

Susan Hogarty, RN, MSN Psychiatric Clinical Nurse Specialist Research Program Administrator ASCEND Program Comprehensive Recovery Services UPMC Western Psychiatric Hospital Pittsburgh, PA

Stacy Martin, LSW Behavioral Health Counselor UPMC Western Psychiatric Hospital Pittsburgh, PA

Vernon Ian Nathaniel, MD Assistant Professor of Psychiatry University of Pittsburgh School of Medicine Medical Director and Attending Psychiatrist Community Treatment Team-Transitional Age UPMC Western Psychiatric Hospital Pittsburgh, PA

Susan Brown Padilla, CPS Senior Peer Specialist UPMC Western Psychiatric Hospital Pittsburgh, PA

Susan Wolfe, MA, LPC Program Director Community Treatment Team (CTT) UPMC Western Psychiatric Hospital Pittsburgh, PA

Panel Moderator

Flavio Chamis

Composer, Conductor, Educator, Music Consultant and Producer

 

 

All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.

 

The following relevant financial relationships were disclosed:

Steven D. Forman, MD, PhD         Stockholder:  Neurocrine              

John M. Kane, MD                       Grant/Research Support:

Otsuka, Lundbeck, Janssen

Consultant:  

Forum, Allergan, Alkermes, Eli Lilly, Genentech, Lundbeck, Intracellular Therapies, Janssen, Johnson & Johnson, Neurocrine, Otsuka, Pierre Fabre, Merck, Reviva, Roche, Sunovion, Takeda, Teva

Stockholder: Vanguard Research Group, LB Pharmaceuticals

Other: Advisory Board: Alkermes, Intracellular Therapies, Lundbeck, Neurocrine, Otsuka, Takeda, Teva, Pierre Fabre

Deanna L. Kelly, PharmD, BCPP             Consultant: Alkermes,  HLS Therapeutics        

 

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 6.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.50 Attendance

Accreditation Period

Course opens: 
11/15/2019
Course expires: 
12/31/2020
Please login or register to take this course.